Abstract
Human lymphatic filariasis although not fatal but poses serious socioeconomic burden due to associated disability. This is reflected by the huge magnitude of the estimated disability-adjusted life years of about 5.09 million. Therefore, following WHO mandate, our earlier studies on antifilarial drug development revealed the significance of apoptosis. Apoptotic impact has been implicated in anticancer rationale of several drugs. In this study, we explored the antifilarial potential of sulphonamido-quinoxaline compounds, shown to be specific inhibitor for c-Met kinase in human cancer cells. Out of studied compounds, Q4, showing favorable drug-likeness and medicinal chemistry properties on bioinformatics platform along with subsequently recorded lowest IC100 value, was considered as a suitable antifilarial candidate. Significant apoptosis due to mitochondrial involvement was recorded in drug-treated parasite unlike untreated control. In spite of homology between human c-Met kinase and Brugia malayi counterpart, comparative docking result of this compound showed more favorable binding parameters with the parasitic target. The wide gap between IC100 and LD50 values further confirmed the therapeutic safety. We propose sulphonamido-quinoxaline derivative as a lead candidate for antifilarial drug development. Further study is warranted to authenticate parasitic c-Met kinase as a novel therapeutic target reminiscent of anticancer rationale implicating inhibition of proliferation.
Similar content being viewed by others
References
Bag S, Tawari NR, Sharma R, Goswami K, Reddy MV, Degani MS (2010) In vitro biological evaluation of biguanides and dihydrotriazines against Brugia malayi and folate reversal studies. Acta Trop 113:48–51
Bahekar SP, Hande SV, Agrawal NR, Chandak HS, Bhoj PS, Goswami K, Reddy MV (2016) Sulfonamide chalcones: synthesis and in vitro exploration for therapeutic potential against Brugia malayi. Eur J Med Chem 124:262–269
Behm CA, Bendig MM, McCarter JP, Sluder AE (2004) WHO/TDR scientific working group on ‘RNA interference as a means of identifying drug targets for filariasis’ report: 1
Behm CA, Bendig MM, McCarter JP, Sluder AE (2005) RNAi-based discovery and validation of new drug targets in filarial nematodes. Trends Parasitol 21:97–100
Bennuru S, Meng Z, Ribeiro JM, Semnani RT, Ghedin E, Chan K, Lucas DA, Veenstra TD, Nutman TB (2011) Stage-specific proteomic expression patterns of the human filarial parasite Brugia malayi and its endosymbiont Wolbachia. Proc Natl Acad Sci U S A 108:9649–9654
Bhattacharjee J (2016) Mass drugs administration in India—a failure story. Epidemiology: Open Access 6:252
Brenk R, Schipani A, James D, Krasowski A, Gilbert IH, Frearson J, Wyatt PG (2008) Lessons learnt from assembling screening libraries for drug discovery for neglected diseases. Chem Med Chem 3:435–444
Csermely P, Korcsmáros T, Kiss HJ, London G, Nussinov R (2013) Structure and dynamics of molecular networks: a novel paradigm of drug discovery: a comprehensive review. Pharmacol Ther 138:333–408
Daina A, Michielin O, Zoete V (2017) SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep 7:42717
Ganapaty S, Ramalingam P, BabuRao CH (2008) SAR study: impact of hydrazide hydrazones and sulfonamide side chain on in vitro antimicrobial activity of quinoxaline. Int J Pharmacology Biology 2:13–18
Hanly EK, Darzynkiewicz Z, Tiwari RK (2015) Biguanides and targeted anti-cancer treatments. Genes Cancer 6:82
Hussain MA, Sitha AK, Swain S, Kadam S, Pati S (2014) Mass drug administration for lymphatic filariasis elimination in a coastal state of India: a study on barriers to coverage and compliance. Infectious Diseases Poverty 3:31
Ingle R, Marathe R, Magar D, Patel HM, Surana SJ (2013) Sulphonamido-quinoxalines: search for anticancer agent. Eur J Med Chem 65:168–186
Kinnamon KE, Engle RR, Poon BT, Ellis WY, McCall JW, Dzimianski MT (2000) Anticancer agents suppressive for adult parasites of filariasis in mongolianjirds. Proc Soc Exp Biol Med 224:45–49
Lowe SW, Lin AW (2000) Apoptosis in cancer. Carcinogenesis 21:485–495
McGarry HF, Plant LD, Taylor MJ (2005) Diethylcarbamazine activity against Brugia malayi microfilariae is dependent on inducible nitric oxide synthase and the cyclooxygenase pathway. Filaria J 4:4
Ojha CR, Joshi B, KC KP, Dumre SP, Yogi KK, Bhatta B, Adhikari T, Crowley K, Marasaini BR (2017) Impact of mass drug administration for elimination of lymphatic filariasis in Nepal. PLoS Negl Trop Dis 11:e0005788
Organ SL, Tsao MS (2011) An overview of the c-MET signaling pathway. Ther Adv Med Oncol 3(1_suppl):S7–S19
Porter J, Lumb S, Lecomte F, Reuberson J, Foley A, Calmiano M, le Riche K, Edwards H, Delgado J, Franklin RJ, Gascon-Simorte JM (2009) Discovery of a novel series of quinoxalines as inhibitors of c-Met kinase. Bioorganic Med Chem Lett 19:397–400
Rao UR, Mehta K, Subrahmanyam D, Vickery AC (1991) Brugia malayi and Acanthocheilonema viteae: antifilarial activity of transglutaminase inhibitors in vitro. Antimicrob Agents Chemother 35:2219–2224
Sänger I, Lämmler G, Kimmig P (1981) Filarial infections of Mastomys natalensis and their relevance for experimental chemotherapy. Acta Trop 38:277–288
Singh SK, Goswami K, Sharma RD, Reddy MV, Dash D (2012) Novel microfilaricidal activity of nanosilver. Int J Nanomedicine 7:1023
Ton TG, Mackenzie C, Molyneux DH (2015) The burden of mental health in lymphatic filariasis. Infectious Diseases Poverty 4:34
Wei Y, Wang D, Gentile CL, Pagliassotti MJ (2009) Reduced endoplasmic reticulum luminal calcium links saturated fatty acid-mediated endoplasmic reticulum stress and cell death in liver cells. Mol Cell Biochem 331:31–40
World Health Organization. Lymphatic filariasis: fact sheet updated on March 2017 http://www.who.int/mediacentre/factsheets/fs102/en/
Acknowledgements
We would like to extend our tribute to the Late Dr. MVR Reddy, for his active contribution in this work.
Funding
This research work was supported by the funding received from the Department of Biotechnology (DBT) (Project Id. BT/PR/4988/INF/22/155/2012) and the Department of Science and Technology (DST-FIST) (Project Id. SR/FST/LSI-470/2010) of the Ministry of Science and Technology, Government of India.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
The animals used for the experimental purpose were approved by the Institutional Animal Ethics Committee (IAEC), MGIMS, Sevagram, Maharashtra, which follows the Committee for the Purpose of Control and Supervision of Experiments on Animals (CPCSEA) norms. Peripheral blood mononuclear cells (PBMCs; 1 × 106 cells/mL) of healthy human volunteers, of age 25 to 30 with informed consent, were collected and have been performed in accordance with the ethical recommendations of the Institutional Ethical Committee, MGIMS, Sevagram.
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Section Editor: Ramaswamy Kalyanasundaram
Rights and permissions
About this article
Cite this article
Bhoj, P.S., Ingle, R.G., Goswami, K. et al. Apoptotic impact on Brugia malayi by sulphonamido-quinoxaline: search for a novel therapeutic rationale. Parasitol Res 117, 1559–1572 (2018). https://doi.org/10.1007/s00436-018-5834-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00436-018-5834-6